Corrigendum to “A Novel Inflammation-Based Risk Score Predicts Mortality in Acute Type A Aortic Dissection Surgery: The Additive Anti-inflammatory Action for Aortopathy and Arteriopathy Score” Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Volume 6, Issue 6, December 2022, Pages 497-510
Hong Liu, MD, PhD; Si-Chong Qian, MD, PhD; Ying-Yuan Zhang, MD; Ying Wu, MD; Liang Hong, MD; Ji-Nong Yang, MD; Ji-Sheng Zhong, MD; Yu-Qi Wang, MD; Dong Kai Wu, MD, PhD; Guo-Liang Fan, MD; Jun-Quan Chen, MD, PhD; Sheng-Qiang Zhang, MD; Xing-Xing Peng, MD; Yong-Feng Shao, MD, PhD; Hai-Yang Li, MD, PhD; and Hong-Jia Zhang, MD, PhD
From the Department of Cardiovascular Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China (H.L., Y.-F.S.); Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, People’s Republic of China (S.-C.Q., H.-Y.L., H.-J.Z.); Department of Cardiovascular Surgery, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of China (Y.-Y.Z.); Department of Laboratory, the First Affiliated Hospital of Shantou University Medical College, Shantou, People’s Republic of China (Y.W.); Department of Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, People’s Republic of China (L.H.); Department of Cardiovascular Surgery, the Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of China (J.-N.Y.); Department of Cardiovascular Surgery, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, People’s Republic of China (J.-S.Z.); Department of Cardiovascular Surgery, Teda International Cardiovascular Hospital, Chinese Academy of Medical Sciences, Tianjin, People’s Republic of China (Y.-Q.W.); Department of Cardiovascular Surgery, Xiangya Hospital, Central South University, Changsha, People’s Republic of China (D.K.W.); Department of Cardiovascular Surgery, Shanghai East Hospital, Tongji University, Shanghai, People’s Republic of China (G.-L.F.); Department of Cardiovascular Surgery, Tianjin Chest Hospital, Tianjin Medical University, Tianjin, People’s Republic of China (J.-Q.C.); Department of Cardiovascular Surgery, the First Affiliated Hospital of Bengbu Medical College, Bengbu, People’s Republic of China (S.-Q.Z.); and Department of Cardiovascular Surgery, the First Affiliated Hospital of Guilin Medical University, Guilin, People’s Republic of China (X.-X.P.).
The authors regret there is a typo in Figure 1 and in Methods section.
Figure 1 showed that “Derivation cohort 3695 patients from Beijing Anzhen Hospital (2016-2021),” we accidentally made a clerical error, Derivation cohort 3695 patients from Beijing Anzhen Hospital was collected from 2002 to 2021. So, 2016-2021 should be corrected to 2002-2021.
Also, Page 501 in Methods Model Validations, “The new mortality model was internally validated using data on 571 patients from the same hospitals as the derivation cohort (2016-2021),” 2016-2021 should be corrected to 2002-2021.
The authors would like to apologize for any inconvenience caused.
DOI of original article: https://doi.org/10.1016/j.mayocpiqo.2022.08.005
Hai-Yang Li, MD, PhD